• Search
  • Advanced Search

Review Article

February 28, 2025


Efficacy of Bisphosphonate in Patients with Neurofibromatosis Type 1
Arzu Jalilova, Alessandra Cocca
J Bone Metab. 2025;32(1):1-10.

This review aims to synthesize current knowledge regarding the use of bisphosphonates (BPs) in the treatment of bone complications in patients with neurofibromatosis type 1 (NF1). NF1 is a genetic...

Original Article

February 28, 2025


Transforming Growth Factor-β Signaling Inhibits the Osteogenic Differentiation of Mesenchymal Stem Cells via Activation of Wnt/β-Catenin Pathway
Mahsa Tahoori, Azita Parvaneh Tafreshi, Fatemeh Naghshnejad, et al.
J Bone Metab. 2025;32(1):11-20.

Background: Due to the contradictory and temporally variable effects of transforming growth factor-β (TGF-β) and the Wnt/β-catenin pathways on osteogenic differentiation in different stem cell types, we sought to examine...

Original Article

February 28, 2025


Pharmacogenetics of Response to Bisphosphonate Treatment in Postmenopausal Osteoporosis: A Prospective Study
Sirin Akbulut Ayturk, Ozden Ozyemisci Taskiran, Ebru Koseoglu Tohma, et al.
J Bone Metab. 2025;32(1):21-30.

Background: This study aims to investigate the effect of genetic polymorphisms of vitamin D receptor (VDR), estrogen receptor 1 (ER1), and Col1a1 on the response to bisphosphonate (BP) therapy in...

Original Article

February 28, 2025


Generate Quantitative Computed Tomography-Equivalent Computed Tomography Image Interpretation Reports in Patients with Spinal Deformities
Hyunbin Kim, Hyeon Su Kim, Shinjune Kim, et al.
J Bone Metab. 2025;32(1):31-37.

Background: Quantitative computed tomography (QCT) is essential for assessing osteoporosis and monitoring spinal deformities. “Clari-QCT,” a software that uses artificial intelligence to analyze conventional computed tomography (CT) scans and produce...

Original Article

February 28, 2025


Incidence of Hypercalcemia and Vertebral Fractures Following Denosumab Withdrawal in Lung Cancer Patients: A Longitudinal Cohort Study
Marta Villanova, Sharon H. Chou, Le Min
J Bone Metab. 2025;32(1):38-48.

Background: Bone-target agents (BTAs), including denosumab (DMAb), are one of the bone metastasis treatments that should continue indefinitely. However, BTAs may be interrupted in some cases. In osteoporosis, DMAb withdrawal...

Original Article

February 28, 2025


Treatment Goals for Prevention of Vertebral Fractures in Patients with Rheumatoid Arthritis
Takeshi Mochizuki, Mari Ando, Koichiro Yano, et al.
J Bone Metab. 2025;32(1):49-56.

Background: Patients with rheumatoid arthritis (RA) are at an increased risk of osteoporosis and vertebral fractures. This study aimed to investigate factors associated with vertebral fractures and treatment goals to...

Original Article

February 28, 2025


Twenty-Year Trends in Osteoporosis Treatment and Post-Fracture Care in South Korea: A Nationwide Study
Kyoung Jin Kim, Kyoung Min Kim, Young-Kyun Lee, et al.
J Bone Metab. 2025;32(1):57-66.

Background: Osteoporosis is a significant public health issue in aging populations. Despite advances in pharmacotherapy, underdiagnosis and undertreatment remain prevalent even in patients with recent fractures. This study examined 20-year...

Letter to the Editor

February 28, 2025


Calcium Supplementation: To Do or Not to Do
Emanuella Graciela Borges Fonseca, Carlos Marques dos Santos, Felipe Freire da Silva, et al.
J Bone Metab. 2025;32(1):67-68.
Current Issue
Volume 32(1); Feb 2025

This archive contains links to the full-text of all issues of J Bone Metab.

Current issue

Volume 32(1); February

All issues

Vol. 32
2025

v.32(1)
Feb 2025
Vol. 31
2024

v.31(1)
Feb 2024
v.31(2)
May 2024
v.31(3)
Aug 2024
v.31(4)
Nov 2024
Vol. 30
2023

v.30(1)
Feb 2023
v.30(2)
May 2023
v.30(3)
Aug 2023
v.30(4)
Nov 2023
Vol. 29
2022

v.29(1)
Feb 2022
v.29(2)
May 2022
v.29(3)
Aug 2022
v.29(4)
Nov 2022
Vol. 28
2021

v.28(1)
Feb 2021
v.28(2)
May 2021
v.28(3)
Aug 2021
v.28(4)
Nov 2021
Vol. 27
2020

v.27(1)
Feb 2020
v.27(2)
May 2020
v.27(3)
Aug 2020
v.27(4)
Nov 2020
Vol. 26
2019

v.26(1)
Feb 2019
v.26(2)
May 2019
v.26(3)
Aug 2019
v.26(4)
Nov 2019
Vol. 25
2018

v.25(1)
Feb 2018
v.25(2)
May 2018
v.25(3)
Aug 2018
v.25(4)
Nov 2018
Vol. 24
2017

v.24(1)
Feb 2017
v.24(2)
May 2017
v.24(3)
Aug 2017
v.24(4)
Nov 2017
Vol. 23
2016

v.23(1)
Feb 2016
v.23(2)
May 2016
v.23(3)
Aug 2016
v.23(4)
Nov 2016
Vol. 22
2015

v.22(1)
Feb 2015
v.22(2)
May 2015
v.22(3)
Aug 2015
v.22(4)
Nov 2015
Vol. 21
2014

v.21(1)
Feb 2014
v.21(2)
May 2014
v.21(3)
Aug 2014
v.21(4)
Nov 2014
Vol. 20
2013

v.20(1)
May 2013
v.20(2)
Nov 2013
Vol. 19
2012

v.19(2)
Nov 2012
Korean Journal of Bone Metabolism1994 (v1 n1) to 2012 (v19 n1)
Vol. 19
2012

v.19(1)
May 2012
Vol. 18
2011
v.18(1)
May 2011 		v.18(2)
Nov 2011
Vol. 17
2010
v.17(1)
May 2010 		v.17(2)
Nov 2010
Vol. 16
2009
v.16(1)
May 2009 		v.16(2)
Nov 2009
Vol. 15
2008
v.15(1)
May 2008 		v.15(2)
Nov 2008
Vol. 14
2007
v.14(1)
May 2007 		v.14(2)
Nov 2007
Vol. 13
2006
v.13(1)
May 2006 		v.13(2)
Nov 2006
Vol. 12
2005
v.12(1)
May 2005 		v.12(2)
Nov 2005
Vol. 11
2004
v.11(1)
May 2004 		v.11(2)
Nov 2004
Vol. 10
2003
v.10(1)
May 2003 		v.10(2)
Nov 2003
Vol. 9
2002
v.9(1)
May 2002 		v.9(2)
Nov 2002
Vol. 8
2001
v.8(1)
May 2001 		v.8(2)
Nov 2001
Vol. 7
2000
v.7(1)
May 2000 		v.7(2)
Nov 2000
Vol. 6
1999
v.6(1)
May 1999 		v.6(2)
Nov 1999
Vol. 5
1998
v.5(1)
May 1998 		v.5(2)
Nov 1998
Vol. 4
1997
v.4(1)
May 1997 		v.4(2)
Nov 1997
Vol. 3
1996
v.3(1)
Apr 1996 		v.3(2)
Nov 1996
Vol. 2
1995
v.2(1)
Apr 1995 		v.2(2)
Nov 1995
Vol. 1
1994
v.1(1)
Apr 1994 		v.1(2)
Nov 1994

Journal of Bone
Metabolism

Print ISSN: 2287-6375
Online ISSN: 2287-7029

ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#1001, Hyundai Kirim Officetel, 42 Seocho-daero 78-gil, Seocho-gu, Seoul 06626, Korea
Tel: +82-2-3473-2231    Fax: +82-70-4156-2230    E-mail: jbm@ksbmr.org                

Copyright © 2025 by The Korean Society for Bone and Mineral Research.

Developed in M2PI

Close layer
prev next